Saadat, Lily V.
Boerner, Thomas
Goldman, Debra A.
Gonen, Mithat
Frankel, Timothy L.
Vakiani, Efsevia
Kingham, T. Peter
Jarnagin, William R.
Wei, Alice C.
Soares, Kevin C.
Solit, David B.
D’Angelica, Michael I.
Funding for this research was provided by:
National Cancer Institute (P30-CA008748)
Article History
Received: 31 May 2020
Accepted: 2 July 2020
First Online: 18 July 2020
DISCLOSURES
: David Solit: served as a consultant/received honoraria from Pfizer, Loxo Oncology, Lilly Oncology, Q.E.D. Therapeutics, Vivideon Therapeutics, and Illumina.